Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites

选择性多聚腺苷酸化通过在内含子和3'UTR位点之间切换来改变蛋白质剂量。

阅读:4
作者:Nicola de Prisco ,Caitlin Ford ,Nathan D Elrod ,Winston Lee ,Lauren C Tang ,Kai-Lieh Huang ,Ai Lin ,Ping Ji ,Venkata S Jonnakuti ,Lia Boyle ,Maximilian Cabaj ,Salvatore Botta ,Katrin Õunap ,Karit Reinson ,Monica H Wojcik ,Jill A Rosenfeld ,Weimin Bi ,Kristian Tveten ,Trine Prescott ,Thorsten Gerstner ,Audrey Schroeder ,Chin-To Fong ,Jaya K George-Abraham ,Catherine A Buchanan ,Andrea Hanson-Khan ,Jonathan A Bernstein ,Aikaterini A Nella ,Wendy K Chung ,Vicky Brandt ,Marko Jovanovic ,Kimara L Targoff ,Hari Krishna Yalamanchili ,Eric J Wagner ,Vincenzo A Gennarino

Abstract

Alternative polyadenylation (APA) creates distinct transcripts from the same gene by cleaving the pre-mRNA at poly(A) sites that can lie within the 3' untranslated region (3'UTR), introns, or exons. Most studies focus on APA within the 3'UTR; however, here, we show that CPSF6 insufficiency alters protein levels and causes a developmental syndrome by deregulating APA throughout the transcript. In neonatal humans and zebrafish larvae, CPSF6 insufficiency shifts poly(A) site usage between the 3'UTR and internal sites in a pathway-specific manner. Genes associated with neuronal function undergo mostly intronic APA, reducing their expression, while genes associated with heart and skeletal function mostly undergo 3'UTR APA and are up-regulated. This suggests that, under healthy conditions, cells toggle between internal and 3'UTR APA to modulate protein expression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。